AJNN

The Academic Journal of Neurology and Neurosurgery deals with Neurology and Neurosurgery accepts articles on these topics. Academic Journal of Neurology and Neurosurgery publishes original research articles, review articles, case reports, editorial commentaries, letters to the editor, educational articles, and conference/meeting announcements.

EndNote Style
Index
Case Report
Wernicke encephalopathy presenting with rare clinical findings: bilateral VI cranial nerve palsy and pontine lesion
Wernicke encephalopathy (WE) is a serious acute neurological condition that is commonly associated with vitamin B1 (thiamine) deficiency due to alcohol abuse, albeit it can also occur in non-alcoholic settings. In cases of thiamine deficiency, a clinical diagnosis of WE is considered when two or more of the classic features—such as ophthalmoplegia, gait ataxia, and confusion—are present. A rare clinical manifestation of WE, including bilateral sixth cranial nerve palsy, ataxia, and pontine involvement on MRI, is described in this report. A 36-year-old male was admitted with complaints of diplopia for five days, along with a one-month history of hallucinations and insomnia. His medical history revealed chronic alcohol dependence, including recent consumption of homemade alcohol shortly before his complaints began. On neurological examination, bilateral restricted lateral gaze was observed. Axial T2-weighted MRI images of the brain showed a hyperintense lesion at the pontine midline. The patient was admitted with a preliminary diagnosis of WE and started on thiamine therapy at 500 mg/day for five days, followed by 200 mg/day and then 100 mg/day, each administered for an additional five days. During the early stages of WE, patients typically exhibit characteristic symptoms such as alterations in mental status, ophthalmoplegia, and ataxia. On T2-weighted MRI, Wernicke encephalopathy is indicated by hyperintense lesions in brain regions with high carbohydrate metabolism, particularly involving the ventral thalamus, hypothalamus, mammillary bodies, periaqueductal gray matter, and the floor of the fourth ventricle. This case has been presented to highlight a rare clinical presentation of Wernicke encephalopathy.


1. Habas E, Farfar K, Errayes N, Rayani A, Elzouki AN. Wernicke encephalopathy: an updated narrative review. Saudi J Med Med Sci. 2023;11(3):193-200. doi:10.4103/sjmms.sjmms_416_22
2. Cantu-Weinstein A, Branning R, Alamir M, et al. Diagnosis and treatment of Wernicke’s encephalopathy: a systematic literature review. Gen Hosp Psychiatry. 2024;87:48-59. doi:10.1016/j.genhosppsych.2024. 01.005
3. Kohnke S, Meek CL. Don’t seek, don’t find: the diagnostic challenge of Wernicke’s encephalopathy. Ann Clin Biochem. 2021;58(1):38-46. doi: 10.1177/0004563220939604
4. Kitaguchi T, Ota Y, Liao E, et al. The role of MRI in the prognosis of Wernicke’s encephalopathy. J Neuroimaging. 2023;33(6):917-925. doi:10. 1111/jon.13143
5. Darussalam SH, Isa MM, Saleh RM, Mohmood A, Razali AM. Nystagmus and abducens nerve palsy as an early presentation of non-alcoholic Wernicke encephalopathy. Cureus. 2024;16(1):e52121. doi:10. 7759/cureus.52121
6. Kuzume D, Morimoto Y, Yamasaki M, Hosomi N. Wernicke encephalopathy with lesions in the bilateral abducens nuclei: a case report. Rinsho Shinkeigaku. 2022;62(11):869-872. doi:10.5692/clinicalneurol.cn-001783
7. Manzo G, De Gennaro A, Cozzolino A, Serino A, Fenza G, Manto A. MR imaging findings in alcoholic and nonalcoholic acute Wernicke’s encephalopathy: a review. Biomed Res Int. 2014;2014:503596. doi:10. 1155/2014/503596
8. Silva AR, Almeida-Xavier S, Lopes M, Soares-Fernandes JP, Sousa F, Varanda S. Is there a time window for MRI in Wernicke encephalopathy—a decade of experience from a tertiary hospital. Neurol Sci. 2023;44(2):703-708. doi:10.1007/s10072-022-06477-y
9. Novo-Veleiro I, Mateos-Díaz AM, Rosón-Hernández B, et al. Treatment variability and its relationships to outcomes among patients with Wernicke’s encephalopathy: a multicenter retrospective study. Drug Alcohol Depend. 2023;252:110961. doi:10.1016/j.drugalcdep.2023.110961
Volume 2, Issue 2, 2025
Page : 32-34
_Footer